Oxford/AstraZeneca: AZD2816

Vaccine Type: Non Replicating Viral Vector

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 1 Trial

  • NCT04973449
    Brazil, United Kingdom of Great Britain and Northern Ireland

Phase 3: 1 Trial

  • NCT04973449
    Brazil, United Kingdom of Great Britain and Northern Ireland

Approvals

This vaccine is not yet approved.

Registered Trials